Evidence map›Paper›PMID 41802839›Full record

ArticleJournal of cutaneous pathology2026

Cutaneous-Only Relapse in T-Cell Prolymphocytic Leukemia With JAK2 Rearrangement.

Francisco Javier Díaz de la Pinta, Iván Prieto-Potín, Rebeca Manso Alonso, Juan Torre Castro, Cristina Serrano Del Castillo, Jesús Frutos Díaz-Alejo, Rocío Nieves Salgado, Socorro María Rodríguez Pinilla

Abstract read
In one paragraph

Article in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francisco Javier Díaz de la PintaPathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.ORCID https://orcid.org/0000-0002-7070-0550
Iván Prieto-PotínPathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Rebeca Manso AlonsoPathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Juan Torre CastroDermatology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Cristina Serrano Del CastilloHematology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Jesús Frutos Díaz-AlejoPathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Rocío Nieves SalgadoHematology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Socorro María Rodríguez PinillaPathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.

Funding

AECCInstituto de Salud Carlos III 15826/004Instituto de Salud Carlos III 41163/005Instituto de Salud Carlos III PI17/02172Instituto de Salud Carlos III PI21/01724Instituto de Salud Carlos III PMP21/00015Madrid Autonomous Community STARTUP2020/L2566
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gene fusionJAK2relapseSKAP1T‐cell prolymphocytic leukemia (T‐PLL)

Identifiers

PMID41802839
PMCPMC13532782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.